(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

MYCO-DIGITAL

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: US

Quick snapshot

MYCO-DIGITAL

ST13

US500000079418319

Class

5, 42

Filing

79418319

Registration

8217373

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

32

Latest update

08/05/2026

Classification

Registered

Trademark type

Word

Nice classes

5, 42

Filing date

01/14/2025

Registration date

04/21/2026

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

04/21/2026

Last transaction

08/05/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

99

Owner location

F-34790 Grabels, FR

Examiner

CARUSO, JAMES J

Law office

O90

Current location

FILE REPOSITORY (FRANCONIA)

Holders and representatives

Holders

S. G. (pessoa física)

Representatives

Jeffrey A. Smith Millen White Zelano and Branigan PC

Technical classification

Nice Classes

Class 5Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Chemical preparations for medical use for mycoplasma detection in cell cultures for use in cell therapy and regenerative medicine; chemical preparations for medical usemedia for cell cultures for medical use in the field of cell therapy quality control; pharmaceutical products containing cultured cells for cell therapy quality control; veterinary productsculture media for cultivating animal cells for veterinary use in the field of animal cell therapy quality control

Class 42

Scientific research; technological research for mycoplasma detection in the field of cell culturescell therapy and regenerative medicine and related manufacturing processesmedical instruments and pharmaceutical studies; computer software design for mycoplasma testing analyses; computer software development for mycoplasma testing analyses; research and development of new products for third parties; conducting of technical project studiesscientific studies in the field of new technologies for cell culturescell therapy and regenerative medicine and scientific feasibility studies; computer software installation; computer software maintenance; updating of computer software; rental of computer software for mycoplasma testing analyses; Software as a Service (SaaS) services featuring software for use in mycoplasma testing analyses

Publications

History of USPTO decisions and trademark events.

32 publications found

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

08/05/2026

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

08/05/2026

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

07/21/2026

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

04/21/2026

R.PR

REGISTERED-PRINCIPAL REGISTER

04/21/2026

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

03/03/2026

PUBO

PUBLISHED FOR OPPOSITION

03/03/2026

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

02/25/2026

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

02/04/2026

XAEC

EXAMINER'S AMENDMENT ENTERED

02/04/2026

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

02/04/2026

GNEA

EXAMINERS AMENDMENT E-MAILED

02/04/2026

CNEA

EXAMINERS AMENDMENT -WRITTEN

02/04/2026

XAEC

EXAMINER'S AMENDMENT ENTERED

01/29/2026

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

01/29/2026

GNEA

EXAMINERS AMENDMENT E-MAILED

01/29/2026

CNEA

EXAMINERS AMENDMENT -WRITTEN

01/29/2026

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

01/15/2026

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

01/15/2026

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

01/15/2026

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

01/15/2026

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

01/15/2026

RFNT

REFUSAL PROCESSED BY IB

08/29/2025

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

08/12/2025

RFRR

REFUSAL PROCESSED BY MPU

08/12/2025

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

06/28/2025

CNRT

NON-FINAL ACTION WRITTEN

06/27/2025

DOCK

ASSIGNED TO EXAMINER

06/23/2025

MAFR

APPLICATION FILING RECEIPT MAILED

03/28/2025

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

03/28/2025

LIMI

LIMITATION FROM ORIGINAL APPLICATION ENTERED

03/25/2025

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

03/06/2025

Continuous trademark protection

Get notified about every new filing that threatens MYCO-DIGITAL or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.